[UNITAID] The transition from efavirenz to dolutegravir (DTG) in HIV treatment is estimated to reduce total carbon emissions by 26 million tons of CO2 equivalent by 2027 thanks to the shift to a treatment formulation that requires less active ingredient. The adoption of DTG reduced the health sector’s overall carbon footprint in low- and middle-income countries by approximately 3-0.4%, a magnitude of reduction – from one single drug – that surpasses many hard-won climate mitigation achievements in both health and
Source link : https://allafrica.com/stories/202407160024.html
Author :
Publish date : 2024-07-16 05:14:28
Copyright for syndicated content belongs to the linked Source.